TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID

NCT02327351 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Primary Immune Deficiency Disorder
Hematopoietic Stem Cell Transplantation

Interventions

OTHER: Biological: TCR alfa beta T cell depletion

Sponsor

Federal Research Institute of Pediatric Hematology, Oncology and Immunology